CAS 1638744-06-5

Linagliptin Related Compound D ((R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione)

CAS: 1638744-06-5

Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi

Fórmula: C₂₅H₂₉BrN₈O₂

Forma y color: Light Yellow Powder

Peso molecular: 552.15968

Ref: 45-1366525

(R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

CAS: 1638744-06-5

(R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

Fórmula: C₂₅H₂₉BrN₈O₂

Pureza: 96%

Peso molecular: 553.45

Ref: 54-OR1115119

Linagliptin Impurity K

CAS: 1638744-06-5

Fórmula: C₂₅H₂₉BrN₈O₂

Pureza: 96%

Forma y color: Solid

Peso molecular: 553.4542

Ref: IN-DA00AQM5

Linagliptin EP Impurity D (Linagliptin USP Related Compound D)

CAS: 1638744-06-5

Fórmula: C₂₅H₂₉BrN₈O₂

Forma y color: Pale Yellow Solid

Peso molecular: 553.47

Ref: 4Z-L-4415

Linagliptin EP Impurity D

CAS: 1638744-06-5

Fórmula: C₂₅H₂₉BrN₈O₂

Peso molecular: 553.47

Ref: ST-EA-CP-L1017

N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin (E/Z Mixture)

CAS: 1446263-39-3, 1638744-06-5

Applications N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin is an impurity of Linagliptin (L465900); a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011)

Fórmula: C₂₅H₂₉BrN₈O₂

Forma y color: Neat

Peso molecular: 553.45

Ref: TR-D282015